Vitalhub Corp. (TSE:VHI) Receives Consensus Rating of “Buy” from Brokerages

Vitalhub Corp. (TSE:VHI) has been given a consensus recommendation of “Buy” by the six brokerages that are currently covering the stock, Marketbeat reports. Five analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokerages that have covered the stock in the last year is C$12.67.

Separately, National Bank Financial dropped their price target on Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 27th.

Vitalhub Price Performance

Shares of VHI opened at C$8.01 on Friday. The firm’s 50 day moving average is C$7.16 and its 200-day moving average is C$7.54. Vitalhub has a 12-month low of C$6.46 and a 12-month high of C$13.81. The stock has a market capitalization of C$506.71 million, a P/E ratio of 66.75, a P/E/G ratio of 1.18 and a beta of 0.91.

Vitalhub (TSE:VHI) last released its quarterly earnings data on Thursday, August 6th. The company reported C$0.03 earnings per share for the quarter. The business had revenue of C$31.74 million during the quarter. Vitalhub had a return on equity of 2.79% and a net margin of 5.89%. As a group, equities research analysts forecast that Vitalhub will post 0.2296467 EPS for the current fiscal year.

About Vitalhub

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.